Xenon Pharmaceuticals Inc. (XENE) quarterly cash flow statement — complete operating, investing & financing history
Xenon Pharmaceuticals Inc. (XENE) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -184.29M | -88.9M | -81.48M | -71.75M | -64.23M | -61.65M | -54.38M | -49.66M | -32.68M | -46.19M | -35.47M | -42.23M | -33.22M | -34.41M | -32.73M | -30.4M | -16.87M | -18.43M | -20.71M | -15.01M |
| Operating CF Margin % | - | - | - | - | - | -822.03% | - | - | - | - | - | - | - | - | - | -23031.82% | -3147.01% | -210.22% | -554.19% | -184.72% |
| Operating CF Growth % | -186.9% | -44.19% | -49.82% | -44.47% | -96.56% | -33.48% | -53.35% | -17.61% | 1.63% | -34.22% | -8.35% | -38.91% | -96.95% | -86.73% | -58.05% | -102.59% | -28.99% | 11.01% | -57.92% | -25.33% |
| Net Income | -213.04M | -102.3M | -105.26M | -90.9M | -84.71M | -65.05M | -65.69M | -62.79M | -57.92M | -47.93M | -44.74M | -48.46M | -47.46M | -41.73M | -37.4M | -37.15M | -31.16M | -19.67M | -25.56M | -15.45M |
| Depreciation & Amortization | 1.15M | 587K | 611K | 641K | 632K | 659K | 633K | 700K | 659K | 586K | 851K | 1.73M | 602K | 354K | 515K | 358K | 375K | 376K | 270K | 209K |
| Stock-Based Compensation | 33.63M | 16.89M | 14.12M | 13.71M | 13.71M | 12.17M | 13.6M | 13M | 14.72M | 9.4M | 9.18M | 8.74M | 8.45M | 5.99M | 5.81M | 5.74M | 5.21M | 3.61M | 2.71M | 2.64M |
| Deferred Taxes | -1.5M | 447K | -1.11M | -701K | -170K | -1.21M | -8.61M | -322K | -333K | 403K | -200K | -156K | -224K | 288K | 5K | -203K | -104K | 258K | 346K | -267K |
| Other Non-Cash Items | -3.57M | -1.14M | 1.12M | 536K | 3.67M | 3.97M | 3.49M | 67K | 9.27M | -2.7M | -33K | -791K | -1.48M | -1.88M | -2.73M | 3.26M | 1.92M | 3.22M | 523K | 420K |
| Working Capital Changes | -949K | -3.38M | 9.05M | 4.96M | 2.62M | -12.19M | 2.19M | -322K | 936K | -5.95M | -522K | -3.3M | 6.89M | 2.56M | 1.07M | -2.4M | 6.89M | -6.23M | 1.01M | -2.57M |
| Change in Receivables | 0 | 205K | -568.87K | 283K | 7.56M | -7.18M | -547K | -83K | 0 | 38K | -294K | 155K | 43K | 226K | 1.51M | 7K | 390K | -155K | 481K | -332K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.37M | -5.6M | 0 | 0 | 0 | 0 | 5.8M | -240K | 0 |
| Change in Payables | 0 | -1.8M | 3.17M | 0 | 869K | -3.78M | 0 | 0 | 0 | 0 | 0 | -3.37M | 5.6M | 0 | 0 | 0 | 0 | -5.8M | 2.97M | 0 |
| Cash from Investing | -738.52M | -407.28M | 62.7M | 38.53M | 82.26M | 34.51M | 98.5M | 498K | 110.72M | -43.19M | -239.73M | 48.03M | 27.9M | 46.62M | -14.34M | -234.1M | 1.32M | -48.89M | -215.43M | 15.57M |
| Capital Expenditures | -408K | -133K | -318K | -281K | -157K | -43K | -783K | -590K | -1.51M | -188K | -78K | -1.2M | -2.13M | -2.21M | -1.75M | -386K | -544K | -212K | -514K | -223K |
| CapEx % of Revenue | - | - | - | - | - | 0.57% | - | - | - | - | - | - | - | - | - | 292.42% | 101.49% | 2.42% | 13.75% | 2.74% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -49.23M | -30.04M | 0 | 0 | 0 | 0 | -20.28M | -144.75M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -213.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.23M | 30.04M | 0 | 0 | 0 | 0 | 20.28M | 144.75M | 0 |
| Cash from Financing | 843.04M | 843.01M | 113.54M | 2.36M | 65K | 1.15M | 12.13M | 0 | 0 | 0 | 324.01M | 29.51M | 0 | 0 | 6K | 699K | 269.89M | 7.88M | 323.95M | 4.76M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 5.51M | 843.01M | 113.73M | 2.39M | 87.2K | 1.15M | 12.08M | 0 | 0 | 0 | 323.98M | 29.51M | 0 | 0 | 0 | 0 | 269.89M | 7.88M | 323.94M | 4.73M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 837.53M | 0 | -191.75K | -33.48K | -22.2K | 0 | 47K | 0 | 0 | 0 | 35K | 0 | 0 | 0 | 6K | 699K | 0 | 0 | 15K | 28K |
| Net Change in Cash | -79.64M | 346.7M | 94.65M | -30.87M | 18.72M | -26.05M | 55.09M | -49.11M | 77.84M | -89.75M | 49.07M | 35.02M | -4.96M | 12.27M | -46.25M | -266.5M | 253.45M | -59.15M | 87.88M | 4.88M |
| Free Cash Flow | -184.69M | -89.03M | -81.8M | -72.03M | -64.39M | -61.7M | -55.17M | -50.26M | -34.19M | -46.38M | -35.54M | -43.43M | -35.35M | -36.62M | -34.48M | -30.79M | -17.41M | -18.64M | -21.22M | -15.23M |
| FCF Margin % | - | - | - | - | - | -822.6% | - | - | - | - | - | - | - | - | - | -23324.24% | -3248.51% | -212.64% | -567.94% | -187.47% |
| FCF Growth % | -186.84% | -44.31% | -48.27% | -43.34% | -88.31% | -33.03% | -55.21% | -15.71% | 3.28% | -26.65% | -3.07% | -41.06% | -103.04% | -96.44% | -62.48% | -102.15% | -24.5% | 11.71% | -52.23% | -18.92% |
| FCF per Share | -1.85 | -1.02 | -1.03 | -0.91 | -0.82 | -0.78 | -0.70 | -0.64 | -0.44 | -0.60 | -0.51 | -0.66 | -0.54 | -0.56 | -0.53 | -0.47 | -0.31 | -0.34 | -0.52 | -0.36 |
| FCF Conversion (FCF/Net Income) | 1.66x | 0.87x | 0.77x | 0.79x | 0.76x | 0.95x | 0.83x | 0.79x | 0.56x | 0.96x | 0.79x | 0.87x | 0.70x | 0.82x | 0.88x | 0.82x | 0.54x | 0.94x | 0.81x | 0.97x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 1.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |